KBR

Pharma HLB opens new office in Boston's Cambridge Innovation Center to bolster international... HLB said it opened a new office in the Cambridge Innovation Center (CIC) in Boston, U.S. to bolster the collaboration and communication between HLB and its U.S. subsidiaries, such ... Lee Han-soo 2024-04-18 4:11 PM

Pharma Hanmi Pharm's novel drug receives INN name 'efpegerglucagon' for treating... The International Nonproprietary Name (INN) of LAPS Glucagon analog (code name HM15136), which Hanmi Pharm is developing as an innovative new drug for treating congenital hyperinsu... Yang Hyeon-su 2024-04-18 3:25 PM

Bio SK biopharmaceuticals inks $58 million deal to transfer non-narcotic painkiller tech to... SK biopharmaceuticals said Thursday it has signed a technology transfer agreement with a Chinese joint venture company, Ignis Therapeutics, for a non-narcotic pain treatment candid... Kim Chan-hyuk 2024-04-18 3:05 PM

Pharma Handok and Swedish Orphan Biovitrum launch joint venture in Korea Handok and Swedish Orphan Biovitrum (Sobi) said they have officially inaugurated their Korean joint venture, Handok-Sobi.Sobi is a global biopharmaceutical company specializing in ... Lee Han-soo 2024-04-18 2:48 PM

Pharma GC Cell’s US affiliate initiates 1st patient dosing for lupus nephritis study GC Cell said its U.S. affiliate Artiva Biotherapeutics has begun administering the first dose to a participant in a phase 1 clinical trial. This trial investigates the combination ... Lee Han-soo 2024-04-18 2:04 PM

Policy Keytruda’s coverage expansion effectively ‘shelved’ The Cancer Disease Review Committee (CDRC) of the Health Insurance Review and Assessment Service (HIRA) has once again deferred its decision on expanding coverage for Keytruda (pem... Kim Yun-mi 2024-04-18 1:55 PM

Pharma Celltrion launches Remsima SC in Denmark Celltrion said it has been awarded the national tender for the world's only infliximab subcutaneous (SC) formulation, Remsima SC, in Denmark, a key Nordic market. Under the agreeme... Korea Biomedical Review 2024-04-18 11:18 AM

Device/ICT Coreline Soft begins non-reimbursed billing for AVIEW NeuroCAD brain CT analysis solution Coreline Soft, a Korean medical AI company, said Thursday that the National Evidence-based Healthcare Collaborating Agency (NECA) has completed “notifying innovative medical techno... Korea Biomedical Review 2024-04-18 11:03 AM

Policy Why does Korea lag behind Japan and Taiwan in long-term management of Covid-19? Almost one year has passed since the World Health Organization (WHO) declared the lifting of a Public Health Emergency of International Concern (PHEIC), but is Korea building a lon... Kim Yun-mi 2024-04-17 11:16 AM

Bio Celltrion announces additional buyback and retirement of its shares Celltrion announced its decision to further buy back and retire its own shares as part of its ongoing efforts to stabilize its stock price and enhance shareholder value.The company... Lee Han-soo 2024-04-17 4:08 PM

Life science Generative AI, top investment priority for 62% of healthcare CEOs: KHIDI report Generative AI has become a top investment priority for 62 percent of CEOs who manage life science companies.According to a report released by the Korea Health Industry Development ... Yang Hyeon-su 2024-04-17 2:34 PM

Policy 'Over 8,000 med students should take classes together, instead of current 3,000' President Yoon Suk Yeol's announcement to push for increasing the medical school enrollment quota and healthcare reform, even after the crushing defeat in the 22nd general election... Kim Eun-young 2024-04-17 3:12 PM

Pharma 'Bowel cleanser pill Orafang is safe for people over 70’ A clinical study has shown that Orafang tablets are safe for people in their 40s and 50s and for the very elderly aged 70 or more.Pharmbio Korea said Tuesday that it presented clin... Kim Chan-hyuk 2024-04-17 4:18 PM

Pharma BNC Korea secures rights for Danish firm’s Alzheimer's and Parkinson's treatments BNC Korea said it secured exclusive distribution rights in five Asian countries for Danish biotech firm Kariya's KP405 and KP404, both Alzheimer's and Parkinson's drug candidates t... Lee Han-soo 2024-04-17 2:19 PM

Hospital Gut microbiome types decide autism spectrum’s severity A new study is drawing attention by claiming that the types of intestinal microorganisms determine the severity of the autism spectrum.Autism spectrum disorder (ASD) is a complex d... Kwak Sung-sun 2024-04-17 4:12 PM

Hospital World Medical Association empowers Korean med students to confront healthcare realities Executives of the World Medical Association (WMA) executives directly answered questions from Korean medical students who said they wanted to change the dark reality of Korean heal... Koh Jung Min 2024-04-17 10:39 AM

Hospital Korean, US researchers develop dual fluorescence imaging technique for... A research team at Korea University Guro Hospital (KUGH) and Harvard Medical School has developed the "world’s first" dual fluorescence imaging technique for precision lung cancer ... Lee Han-soo 2024-04-17 11:05 AM

Pharma Tagrisso-chemo combo expands indication for 1st-line NSCLC treatment AstraZeneca Korea's Tagrisso (osimertinib) has expanded its indication to include the first-line treatment of EGFR-mutated non-squamous NSCLC.The Ministry of Food and Drug Safety o... Kim Chan-hyuk 2024-04-17 10:43 AM

Hospital ‘Goal of treating hemophilia is to normalize life like a non-patient’ The history of hemophilia treatment over the past 100 years has been remarkable, from plasma transfusions to the development of clotting factors and to the advent of antibody and g... Kim Yun-mi 2024-04-16 1:10 PM

Pharma Keytruda gets additional indication for treating high-risk cervical cancer MSD Korea said Tuesday that it has received approval from the Ministry of Food and Drug Safety (MFDS) to expand the indication of its anti-PD-1 immuno-oncology drug Keytruda (pembr... Kim Kyoung-Won 2024-04-16 2:45 PM

Hospital ‘Cancer patients with emotional difficulties are not getting the care they need’ Studies have shown that high levels of distress at the time of cancer diagnosis are associated with a higher risk of recurrence and death.According to an expert, however, only 10 p... You Ji-young 2024-04-16 3:27 PM

Policy Nearly 75% of Korean healthcare service laborers worked 5 years or less The share of workers with "five years or less" years of career in the healthcare service industry stood at 73.4 percent, higher than in other industries, a local report showed.In a... Yang Hyeon-su 2024-04-16 4:58 PM

Pharma Daewoong Bio renews telmisartan lineup with moisture-resistant formulation Daewoong Bio said the company has changed its entire lineup of tablets containing telmisartan, an ingredient for treating hypertension, into moisture-resistant tablets to solve the... Yang Hyeon-su 2024-04-16 4:28 PM

Policy Despite election defeat, Yoon remains unchanged in pushing ‘medical reform’ President Yoon Suk Yeol reiterated his stance to increase the medical school enrollment quota and push for healthcare reform in his first statement after the April 10 parliamentary... Kwak Sung-sun 2024-04-16 1:05 PM

Hospital Immunotherapy offers encouraging treatment outcomes for small cell lung... Compared to non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), which accounts for about 15 percent of all lung cancer, is very aggressive, growing and spreading rap... Kim Kyoung-Won 2024-04-16 3:02 PM

Hospital Anxiety and anger increase pain in people with somatic symptom disorder A "somatic symptom disorder" is a condition in which physical symptoms, including pain, fatigue, indigestion, or dizziness, persist without a clear cause.These symptoms can be very... Korea Biomedical Review 2024-04-16 11:42 AM

Policy Korean regulator bans foreign supplements with diphenhydramine, yellow oleander The Ministry of Food and Drug Safety said on Tuesday that it banned foreign-made dietary supplements containing or made with prohibited ingredients that could cause side effects li... Korea Biomedical Review 2024-04-16 11:34 AM

Pharma EuBiologics’ simplified oral cholera vaccine wins WHO prequalification certification EuBiologics said on Tuesday that its Euvichol-S, a simplified formulation of the oral cholera vaccine co-developed with the International Vaccine Institute (IVI), has obtained preq... Korea Biomedical Review 2024-04-16 10:12 AM

Opinion [Column] Why eating microplastics is harmful We inhabit a plastic-laden world where plastic fragments into minuscule pieces, rather than decomposing. These plastic particles have been discovered by scientists in various human... Jeong Jae-hoon 2024-04-15 4:06 PM

Pharma DongKoo Bio & Pharma becomes Qurient's largest shareholder through strategic... DongKoo Bio & Pharma, a Korean company known for its dermatological products, has announced a strategic investment of 10 billion won ($7.2 million) into Qurient, a local biotech, b... Lee Han-soo 2024-04-15 4:13 PM

Hospital 1,300 trainee doctors sue health minister, vice minister for ‘trampling on them and... Trainee doctors have filed a class action lawsuit against Minister of Health and Welfare Cho Kyoo-hong and Vice Minister Park Min-soo.The top two health officials were accused of a... Koh Jung Min 2024-04-15 4:46 PM

Hospital ‘Domestic DLBCL secondary care landscape at its most vulnerable’ Diffuse large B-cell lymphoma (DLBCL) is the most frequent subtype of non-Hodgkin's lymphoma, which accounts for the majority of lymphomas. In addition, the number of B-cell lympho... Kim Chan-hyuk 2024-04-15 4:33 PM

Special BMS exec celebrates winning nod for 6 drugs in Korea in 2 years Unlike many other global pharmaceutical giants choosing to divest and spin-off units, Bristol Myers Squibb (BMS) is aggressively expanding its pipeline through open innovation and ... Lee Han-soo 2024-04-15 11:10 AM

Hospital Emergency doctors group urges media not to stigmatize ERs unable to accept patients A patient with an aortic dissection who was transferred from Busan to Ulsan died a few days after surgery. The bereaved family filed a complaint with the Anti-Corruption and Civil ... Koh Jung Min 2024-04-15 1:02 PM

Hospital CHA Bundang Medical Center teams up with Rutgers University for R&D CHA Bundang Medical Center (CBMC) has signed an agreement with Rutgers University, a prestigious public university in the United States, for joint research and technology developme... Korea Biomedical Review 2024-04-15 3:31 PM

Pharma Handok secures exclusive rights to distribute Nxera Pharma's stroke prevention Pivlaz Handok said it finalized an exclusive distribution and supply agreement with Nxera Pharma Korea, the offshoot of a Japan-based pharmaceutical company Nxera, for Pivlaz, a drug desi... Lee Han-soo 2024-04-15 2:40 PM

Pharma Minister applauds Geo-Young's advanced cold chain logistics in pharmaceutical distribution Pharmaceutical products are difficult to develop, manufacture, and produce, as they are directly linked to human lives. Moreover, the importance of drug distribution management has... Yang Hyeon-su 2024-04-15 1:50 PM

Pharma Yuyu Pharma is buoyed by cruising CMO business Yuyu Pharma said its contract manufacturing organization (CMO) business, a new growth engine, is on a roll with a series of contract signings.This month, the company signed new CMO... Korea Biomedical Review 2024-04-15 1:15 PM

Device/ICT Lunit moves closer to acquiring Volpara by winning shareholders’ nod Lunit, a Korean medical AI company, has moved closer to acquiring Volpara Health Technologies, a New Zealand company specializing in AI-powered cancer examining software.Volpara sa... Kim Chan-hyuk 2024-04-15 11:20 AM

Hospital Innovative bone regeneration technology developed by Yonsei University researchers A technology that sequentially releases antibiotics and growth agents to enhance bone regeneration has been developed by a collaborative research team from Yonsei University.Patien... Lee Han-soo 2024-04-12 3:47 PM

Hospital [A to Z of Lou Gehrig’s disease] Reasons why it's important to identify genetic variants ... Amyotrophic lateral sclerosis (ALS), more commonly known as Lou Gehrig's disease, is a rare disorder first recognized in the 1930s when the famous New York Yankees baseball player ... Kim Kyoung-Won 2024-04-12 4:07 PM

Pharma OliX Pharmaceuticals unveils preclinical data for hair loss treatment at World Congress... OliX Pharmaceuticals, a Korean biotech firm specializing in RNA interference technologies, recently announced the promising results of its hair loss treatment, OLX104C, at the 13th... Lee Han-soo 2024-04-12 5:00 PM

Pharma ‘Aggressive interferon treatment needed to reach MRD in myeloproliferative neoplasms’ PharmaEssentia Korea said it hosted a myeloproliferative neoplasms (MPN) forum to share the latest insights on Besremi (ropeginterferon alfa-2b), a treatment for polycythemia vera ... Kim Chan-hyuk 2024-04-12 2:44 PM

Bio Samsung Bioepis secures 1st approval in Korea for Stelara biosimilar Samsung Bioepis has achieved a significant milestone by obtaining the first domestic approval for a biosimilar referencing Janssen's Stelara, Epyztek (ingredient: ustekinumab), on ... Lee Han-soo 2024-04-12 1:52 PM

Opinion [Reporter’s Notebook] Election results reflect public call for revision in medical school... "I will humbly accept the people's will expressed in the parliamentary election and do my best to renew the state administration and stabilize the economy and people's livelihood."... Kwak Sung-sun 2024-04-12 1:23 PM

Pharma Janssen's Rybrevant makes 3rd attempt for reimbursement. Will it succeed? Janssen's Rybrevant (amivantamab), a treatment for EGFR exon20 insertion non-small cell lung cancer (NSCLC), a rare form of lung cancer with a poor prognosis, is making its third a... Kim Yun-mi 2024-04-12 11:23 AM

Policy Court rejects doctors' group exec's request for stopping license suspension A Seoul court has rejected a request for an enforcement halt of the medical license suspension filed by Kim Taek-woo, chairman of the emergency committee of the Korean Medical Asso... Koh Jung Min 2024-04-12 10:39 AM

Bio Celltrion secures major PBM contract for Yuflyma in the US Celltrion said Yuflyma (ingredient: adalimumab), a biosimilar referencing Humira, has been included in the formulary of one of the top three pharmacy benefit managers (PBMs) in the... Lee Han-soo 2024-04-12 10:40 AM

Device/ICT Experts lament obstacles to expanding DTx prescriptions Following Somzz, the first digital treatment device (DTx) in Korea, WELT-I has won approval from the Ministry of Food and Drug Safety and has begun to be prescribed to patients. St... Kim Eun-young 2024-04-11 3:58 PM

Pharma NKMAX to challenge delisting decision by Korea Exchange NKMAX, a local biotech firm specializing in NK cell therapy, announced plans to file an objection to its potential delisting from the Korea Exchange (KRX).The company, which has be... Lee Han-soo 2024-04-11 5:05 PM

상단영역

본문영역